Optimizing Patient Outcomes using Drug-Eluting Stent Technology

Optimizing Patient Outcomes using Drug-Eluting Stent Technology

On-Demand Webcast

David Kandzari, MD, FACC, FSCAI
Chief Scientific Officer, Piedmont Healthcare
Director Interventional Cardiology, Piedmont Heart Institute
Atlanta, Georgia

Ron Waksman, MD, FACC, FSCAI
Professor of Medicine, Georgetown University
Director of Cardiovascular Research and Advanced Education
MedStar Heart & Vascular Institute
Washington D.C.

James B. Hermiller, Jr., MD, FACC, MSCAI
Director of Interventional Cardiology
St. Vincent Medical Group
St. Vincent Heart Center of Indiana
Indianapolis, Indiana

Intended Learners

This activity is designed for interventional cardiologists, vascular surgeons, interventional radiologists, cardiothoracic surgeons, clinical cardiologists, nurses, technicians and others involved in the treatment of complex coronary lesions.

Learning Objectives

After completing this activity, participants should be able to:

  • Identify various patient subsets and best treatment options based on the lesion type, disease and patient presentation.
  • Understand recent and ongoing clinical trials for drug-eluting stent technology.
  • Compare and contrast the indications for various drug-eluting stents.
Activity Overview

This on-demand webcast is available with synchronized slides and audio.

In order to be eligible for documentation of credit, participants must attend the full webcast, complete the 10-question post-test with a score of 75% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Release Date: December 20, 2018
Expiration Date: December 31, 2019
Estimated time to complete: 1 hour

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

The evaluation is accessible after the activity via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.


  In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.



NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 credit.

PAs should only claim credit commensurate with the extent of their participation.


This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.


Optimizing Patient Outcomes using Drug-Eluting Stent Technology is approved for 1 ARRT Category A CE credit by The Association for Medical Imaging Management, AHRA. 

AHRA is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).

Planning Committee

The planning committee comprises David Kandzari, MD, FACC, FSCAI; Ron Waksman, MD, FACC, FSCAI; James B. Hermiller Jr., MD, FACC, MSCAI; Robert S. Dieter, MD, RVT, FACC; and MaryEllen Fama, Caitlin Eastman, Todd Kunkler, Jennifer Ilcyn, Randy Robbin, Colleen Waters, and Susan Yarbrough, NACCME.

Independent Clinical Reviewer: Robert S. Dieter, MD, RVT, FACC, Loyola University Medicine, Chicago, Illinois

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Kandzari: Consultant - Biotronik, Boston Scientific, Medtronic; Grant/Research Support - Biotronik, Boston Scientific, Medtronic

Dr. WaksmanConsultant - Biosensors, Biotronik, Cardioset, Cardiovascular Systems Inc., Pi-Cardia LTD, Abbott Vascular, Amgen, Boston Scientific, Medtronic, Philips Volcano; Speakers' Bureau - AstraZeneca, Chiesi; Other Financial or Material Support - MedAlliance

Dr. Hermiller: Consultant - Boston Scientific, Edwards Lifescience, Abbott Vascular, Medtronic

Dr. Dieter, Ms. Fama, Ms. Eastman, Mr. Kunkler, Ms. Ilcyn, Mr. Robbin, Ms. Waters, and Ms. Yarbrough have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed that no off-label/unapproved uses of drugs and/or devises will be discussed in the presentations.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2018 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

Supported by an educational grant from BIOTRONIK, Inc.